Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli n3-yl-2,3-dihydroimidazo[4,5-c]quinolin-1 -yl)-phenyl] -propionitrile

Details for Australian Patent Application No. 2012202996 (hide)

Owner Novartis AG

Inventors Stowasser, Frank; Garad, Sudhakar Devidasrao; Banziger, Markus

Agent Davies Collison Cave

Pub. Number AU-A-2012202996

Parent 2007323820

Filing date 22 May 2012

Wipo publication date 14 June 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2012 Complete Application Filed

14 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202996

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202997-An Automobile Display Panel Assembly

2012202995-A swimming pool